a6e63a60-f8ad-4ca7-8d6c-2ed6e8f26f50.pdf



BioWa, Inc.

212 Carnegie Center, Suite 101, Princeton, NJ, USA www.kyowa-kirin.com/biowa


News Release


BioWa Announces Office Relocation to Princeton, NJ and appointment of New President and CEO


Princeton, NJ / April 1, 2016 -- BioWa, Inc. ("BioWa") today announced that it was relocating its office from La Jolla, California to Princeton, New Jersey, and appointment of Mr. Takeshi Masuda, as the President and CEO for the next stage of corporate development.


Mr. Masuda has also served as President of Kyowa Kirin USA Holdings, Inc. the holding company of Kyowa Hakko Kirin's US pharmaceutical subsidiaries.


BioWa develops partnerships with pharmaceutical companies and biotechs through the licensing of proprietary therapeutic antibody technologies POTELLIGENT® and COMPLEGENT®. These technologies were developed by Kyowa Hakko Kirin, Co. Ltd. and BioWa will be continuing a role as the exclusive worldwide licensor of those technologies after relocation to Princeton.


About BioWa


BioWa is a wholly owned subsidiary of Kyowa Hakko Kirin Co., Ltd. (President and CEO: Nobuo Hanai, Ph.D.), a leading biopharmaceutical company in Japan, and is the exclusive worldwide licensor of the AccretaMab® platform. The AccretaMab® platform consists of POTELLIGENT® and COMPLEGENT® Technologies, creating a superior antibody molecule with enhanced ADCC and Complement-Dependent Cytotoxicity (CDC) activities. BioWa is offering POTELLIGENT® and COMPLEGENT® Technologies to partners under a license to maximize the value of these technologies. Together with Kyowa Hakko Kirin Co., Ltd., BioWa is committed to promoting ADCC/CDC-enhanced monoclonal antibody-based therapeutics to fight cancer and other life-threatening and debilitating diseases. For more information about BioWa, visit our web site at www.kyowa-kirin.com/biowa. POTELLIGENT®, COMPLEGENT®, and AccretaMab® are the registered trademarks of Kyowa Hakko Kirin Co., Ltd. All rights are reserved.


BioWa Contact Information


212 Carnegie Center, Suite 101, Princeton, NJ, USA Tel +1 609 580 7340

Contact form http://www.kyowa-kirin.com/biowa/contact_us/index.html

Kyowa Hakko Kirin Co. Ltd. issued this content on 01 April 2016 and is solely responsible for the information contained herein. Distributed by Public, unedited and unaltered, on 01 April 2016 10:08:05 UTC

Original Document: http://www.kyowa-kirin.com/biowa/news_releases/pdf/2016/160401-biowa-relocation-and-new-president-ceo-announcement.pdf